Abbreviations and Acronyms |
|
xxi | |
|
|
1 | |
|
|
2 | (1) |
|
Committee's Approach to Its Charge |
|
|
3 | (3) |
|
Evidence Reviewed by the Committee |
|
|
6 | (1) |
|
The Committee's Conclusions |
|
|
7 | (8) |
|
Committee Recommendations |
|
|
15 | (4) |
|
|
19 | (18) |
|
|
21 | (1) |
|
The Current Population of Vietnam Veterans |
|
|
22 | (2) |
|
Conclusions of Previous Veterans and Agent Orange Reports |
|
|
24 | (10) |
|
Organization of This Report |
|
|
34 | (3) |
|
2 Evaluating the Evidence |
|
|
37 | (28) |
|
|
37 | (1) |
|
Define the Evaluation Parameters |
|
|
37 | (10) |
|
Compilation of Evidence for Evaluation |
|
|
47 | (4) |
|
Categorization of Types of Evidence |
|
|
51 | (3) |
|
Define the Evaluation Approach |
|
|
54 | (11) |
|
3 Exposure to the Herbicides Used in Vietnam |
|
|
65 | (28) |
|
Military Use of Herbicides in Vietnam |
|
|
66 | (2) |
|
TCDD in Herbicides Used in Vietnam |
|
|
68 | (2) |
|
Exposure of Vietnam Veterans |
|
|
70 | (6) |
|
Exposure of the Vietnamese Population |
|
|
76 | (2) |
|
Models for Characterizing Herbicide Exposure |
|
|
78 | (8) |
|
Methodologic Issues in Exposure Assessment |
|
|
86 | (7) |
|
4 Information Related to Biological Plausibility |
|
|
93 | (40) |
|
|
97 | (3) |
|
|
100 | (6) |
|
Phenoxy Herbicides: 2,4-Dichlorophenoxy Acid and 2,4,5-Trichlorophenoxyacetic Acid |
|
|
106 | (4) |
|
2,3,7,8-Tetrachlorodibenzo-p-dioxin |
|
|
110 | (16) |
|
Overarching Toxicologic Issues Related to the Chemicals of Interest |
|
|
126 | (7) |
|
5 Epidemiologic Studies: Compendium of New Publications |
|
|
133 | (12) |
|
New Epidemiologic Publications |
|
|
134 | (11) |
|
6 Epidemiologic Studies: Background on Multiply Referenced Populations |
|
|
145 | (118) |
|
|
147 | (32) |
|
|
179 | (36) |
|
|
215 | (38) |
|
|
253 | (10) |
|
7 Immune-System Disorders |
|
|
263 | (24) |
|
Categories of Immune Dysfunction |
|
|
264 | (4) |
|
Conclusion from VAO and Previous Updates |
|
|
268 | (10) |
|
Update of the Epidemiologic Literature and Human Studies |
|
|
278 | (1) |
|
|
279 | (3) |
|
|
282 | (1) |
|
|
283 | (1) |
|
Translation Between Animal and Human Studies |
|
|
284 | (3) |
|
|
287 | (368) |
|
Organization of Cancer Groups |
|
|
290 | (1) |
|
|
291 | (4) |
|
The Committee's View of "General" Human Carcinogens |
|
|
295 | (3) |
|
Oral, Nasal, and Pharyngeal Cancers |
|
|
298 | (16) |
|
Cancers of the Digestive Organs |
|
|
314 | (71) |
|
|
316 | (9) |
|
|
325 | (15) |
|
|
340 | (18) |
|
|
358 | (14) |
|
|
372 | (13) |
|
|
385 | (10) |
|
|
395 | (19) |
|
|
414 | (6) |
|
|
420 | (17) |
|
|
437 | (20) |
|
|
439 | (12) |
|
Basal-Cell and Squamous-Cell Cancers (Non-Melanoma Skin Cancers) |
|
|
451 | (6) |
|
|
457 | (16) |
|
Cancers of the Female Reproductive System |
|
|
473 | (12) |
|
|
485 | (22) |
|
|
507 | (7) |
|
|
514 | (15) |
|
|
529 | (11) |
|
|
540 | (15) |
|
|
555 | (9) |
|
Lymphohematopoietic Cancers |
|
|
564 | (91) |
|
|
569 | (17) |
|
|
586 | (32) |
|
|
618 | (13) |
|
|
631 | (2) |
|
|
633 | (19) |
|
Non-Malignant Myeloid Diseases |
|
|
652 | (3) |
|
9 Effects on Veterans' Fertility and Reproductive Success |
|
|
655 | (44) |
|
Biologic Plausibility of Effects on Fertility and Reproduction |
|
|
657 | (1) |
|
|
658 | (6) |
|
|
664 | (18) |
|
Spontaneous Abortion, Stillbirth, Neonatal Death, and Infant Death |
|
|
682 | (7) |
|
Birth Weight and Preterm Delivery |
|
|
689 | (10) |
|
10 Effects on Veterans' Descendants |
|
|
699 | (44) |
|
Biologic Plausibility of Effects in Veterans' Descendants |
|
|
702 | (7) |
|
|
709 | (16) |
|
|
725 | (9) |
|
Effects Occurring Later in Offspring's Life or in Later Generations |
|
|
734 | (9) |
|
|
743 | (38) |
|
|
746 | (2) |
|
Neurobehavioral (Cognitive or Neuropsychiatric) Disorders |
|
|
748 | (2) |
|
Neurodegenerative Diseases |
|
|
750 | (24) |
|
Chronic Peripheral System Disorders |
|
|
774 | (4) |
|
|
778 | (3) |
|
12 Cardiovascular and Metabolic Outcomes |
|
|
781 | (60) |
|
|
782 | (20) |
|
|
802 | (39) |
|
13 Other Chronic Health Outcomes |
|
|
841 | (62) |
|
|
843 | (30) |
|
Gastrointestinal and Digestive Diseases, Including Liver Toxicity |
|
|
873 | (7) |
|
|
880 | (2) |
|
Thyroid Homeostasis or Other Endocrine Functions |
|
|
882 | (16) |
|
|
898 | (1) |
|
|
899 | (4) |
|
14 Conclusions and Recommendations |
|
|
903 | (144) |
|
Synopsis of Committee Conclusions |
|
|
903 | (3) |
|
Committee Recommendations |
|
|
906 | (21) |
|
|
927 | (120) |
|
|
|
A Issues Raised by the Public and Agendas of Public Meetings Held by the Committee and Other Written Submissions to the Committee |
|
|
1047 | (10) |
|
B Short-Term Adverse Health Responses |
|
|
1057 | (10) |
|
C Clarification of Cancer Groupings Used in Reporting Results, with Correspondence to National Institute for Occupational Safety and Health Cause-of-Death Codes and International Classification of Diseases Codes for Cancers |
|
|
1067 | (10) |
|
D Committee and Staff Biographies |
|
|
1077 | |